2 edition of Progress in chemotherapy (antibacterial, antiviral, antineoplastic) found in the catalog.
Progress in chemotherapy (antibacterial, antiviral, antineoplastic)
International Congress of Chemotherapy Athens 1974
|Contributions||Daikos, George K, Papanastassiou, D.N., Greece. Hypourgeion Politismou kai Epistēmōn|
|LC Classifications||RM262.2 I58 1974|
|The Physical Object|
|Pagination||3 v. :|
The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any. The book is divided into three sections: Retrospectoscope (chapters 1 and 2), Present Treatment (chapters 3–12), and The Future (chapters 13–25). Section 1 deals with the early history of drug development and the important clinical trials which established the short course chemotherapy regimen with which we are familiar today.
Experimental and Clinical Progress in Cancer Chemotherapy Book Summary: As in CANCER CHEMOTHERAPY 1, this volume brings to the reader highlights in three different areas of cancer therapeutics: new concepts and models; drug classes; and clinical settings. Topics were chosen because of their timeliness or probable current impact in cancer treatment. As highlighted in the AACR Cancer Progress Report , progress against cancer has continued at a spectacular pace since the start of In fact, during the five years of publishing the AACR Cancer Progress Report, the number of FDA-approved therapeutics targeting specific molecules involved in cancer more than doubled, reaching 52 Cited by:
About this Book Chemotherapy and You is written for you—someone who. is about to receive or is now receiving chemotherapy for cancer. Your family, friends, and others close to you may Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to destroy cancer cells. Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy herapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy).Other names: chemo.
Moose Jaw River study
The German language and the real world
The wonderful works of God are to be remembered.
Decolonizing European sociology
Reauthorization of the Follow Through Program
Letter to Peter Olds
historical study of the American funeral.
Manual of British birds
Dark villa of Capri
Ornamental flowering shrubs in Australia
The Faerie Queene (Books I to III)
Progress in antimicrobial and anticancer chemotherapy;: Proceedings Hardcover – January 1, See all formats and editions Hide other formats and editions. Price New from Used from Hardcover, January 1, "Please retry" — Format: Hardcover.
The first randomized trial evaluating adjuvant chemotherapy in breast cancer was the National Surgical Adjuvant Breast and Bowel Project (NSABP) B trial initiated inwhich reported in that an adjuvant alkylating agent (thiotepa) given after radical mastectomy significantly decreased recurrence rate in pre-menopausal women with four or more positive axillary lymph nodes .Cited by: Progress in Anti-Cancer Chemotherapy [David Khayat, Gabriel N.
Hortobagyi] on *FREE* shipping on qualifying offers. This is the fourth volume of our series Progress in Anti-cancer Therapy. For the past four years we have taken the challenge to select each year.
Progress in Anti-Cancer Chemotherapy. by Gabriel N. Hortobagyi,David Khayat. Progress in Anti-Cancer Chemotherapy (Book 3) Thanks for Sharing. You submitted the following rating and review.
We'll publish them on our site once we've reviewed : Springer Paris. This book will prove useful to oncologists and other workers in the medical profession with background of chemotherapy. Show less Advances in Chemotherapy, Volume 1 presents the significant progress both in theoretical and experimental aspects in the various disciplines comprising chemotherapy field.
A year-old journalist responded to her diagnosis with questions — lots of them. In “Radical,” she delivers the facts and the story of her treatment. Advances in Chemotherapy, Volume 2 provides comprehensive and authoritative surveys of progress in all fields of experimental and applied chemotherapy.
This book is composed of six chapters, and begins with a discussion on the chemical control of nematodes in plants and the chemistry, biochemistry, and anti-infectious properties of. Experimental and Clinical Progress in Cancer Chemotherapy.
Cancer Treatment and Research (Book 24) Thanks for Sharing. You submitted the following rating and review. We'll publish them on our site once we've reviewed : Springer US. Book Notes | 1 June Progress In Chemotherapy. Abstract. Papers from the Eighth International Congress of Chemotherapy, held in Athens in September group topics include bacterial resistance, mechanisms of chemotherapeutic action, pharmacokinetics, experimental chemotherapy, antimycotic and antiparasitic chemotherapy, anaerobic.
Genre/Form: Congress: Additional Physical Format: Online version: International Congress of Chemotherapy (8th: Athens). Progress in chemotherapy. ISBN: OCLC Number: Description: pages: illustrations ; 24 cm.
Contents: Vol 3. c Series Title: Progress in anti-cancer. This is the fourth volume of our series Progress in Anti-cancer Therapy.
For the past four years we have taken the challenge to select each year, some of the most interesting topics on the wide field of oncology. This is the third volume of our series Progress in Anti-Cancer Chemo therapy.
Following the strategy of the first two volumes, it covers selected aspects of progress in this fast moving field of Oncology, with contribu tions from some of the world's best known leaders in both basic and clin ical.
This is the third volume of our series Progress in Anti-Cancer Chemo therapy. Following the strategy of the first two volumes, it covers selected aspects of progress in this fast moving field of Oncology, with contribu tions from some of the world's best known leaders in both basic and clin ical research.
This is the fourth volume of our series Progress in Anti-cancer Therapy. For the past four years we have taken the challenge to select each year, some of the most interesting topics on the wide field of oncology. As usual, this volume continues the tradition and covers five cancers (breast. This Review summarizes progress in applying nanotechnology to cancer treatment and discusses the challenges of clinical translation and opportunities to develop more effective nanotherapeutics Cited by: The two main types of lung cancer are small cell lung cancer and non-small cell lung cancer (NSCLC), which is the most common.
About 85 percent of lung cancers are NSCLCs. Primary treatment options for people with NSCLC include surgery, radiation therapy, other local treatments, chemotherapy, immunotherapy, and targeted therapies.
TY - JOUR. T1 - Progress in chemotherapy for advanced gastric cancer. AU - Xu, Rui Hua. AU - Teng, Kai Yuan. PY - /1/1. Y1 - /1/1. N2 - With the rapid development in cytotoxic agents and molecular targeting drugs, some progress in palliative chemotherapy for advanced gastric cancer has been achieved and the median survival of advanced gastric cancer patients is prolonged to about one Cited by: 2.
The response of cancer patients to chemotherapy follows a very heterogeneous pattern. Pharmacogenetics is the study of inherited differences in interindividual drug disposition and effects, with the goal of selecting the optimal drug therapy and dosage for each patient.
Pharmacogenetics for cancer treatment is very significant, as cancer therapies exhibit severe systemic toxicity and Author: Munindra Ruwali.
In consultation with Dr. William Rayburn, Dr. Muller has put together an issue designed to educate the reader on the rapid progress in Gynecologic Cancer Care. More than any other field in obstetrics and gynecology, gynecologic oncology has seen an explos.
The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive s: 1.Content: The book is organized into five parts, which cover cytotoxic therapy, immunology, radiotherapy, clinical management, and chemoprevention of malignancy.
It takes a topical approach to several types of cancer, such as colorectal, breast, head and neck, and lung cancer and by: 5.
DOI: /JCO Journal of Clinical Oncology - published online before print Septem PMID: Chemotherapy: What Progress in the Last 5 Years?Cited by: